Newsroom | 19901 results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of patients with rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, today announced it has successfully removed Catalent Indiana LLC (part of Novo Nordisk) as a commercial fill-finish facility from its apitegromab Biologics License Application (BLA) for the treatment of spinal muscular atrophy (SMA) in...

ST. LOUIS--(BUSINESS WIRE)--The U.S. Food & Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2® test, providing patients and health care professionals with an accurate, accessible, and scalable blood test to help diagnose Alzheimer’s disease in conjunction with standard clinical workup. An estimated 19-20 million U.S. adults aged 65 and older, and hundreds of thousands more between ages 45 and 65 are living with cognitive impairment and may benefit from an early diagnosis1....

SUNNYVALE, Calif.--(BUSINESS WIRE)--IDT expands DNA synthesis offering with high-diversity oligonucleotide capabilities, accelerating customer innovation from development through scale....

PHILADELPHIA--(BUSINESS WIRE)--iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM...

SAN JOSE, Calif.--(BUSINESS WIRE)--Complete Genomics, a U.S.-based provider of end-to-end DNA sequencing platforms, reagents and software, today announced the appointment of entrepreneur, investor and film producer Lauren Selig to its board of directors. Selig is the founder of Shake and Bake Productions and leads an investment fund focused on companies across artificial intelligence, space, biotechnology, media and other emerging technologies, while producing award-winning film, television and...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Soft Bones, a global patient advocacy organization, urged the South Korean government to improve treatment access for HPP patients in a formal letter....

PALO ALTO, Calif.--(BUSINESS WIRE)--Network Bio to Build the First Cell-Free RNA Sequence Foundation Model for General Medical Intelligence with NVIDIA...

PALO ALTO, Calif.--(BUSINESS WIRE)--Network Bio Launches with $50 Million Financing and World’s Largest Patient Tissue Training Dataset...

PALO ALTO, Calif.--(BUSINESS WIRE)--Greenstone Biosciences has been awarded a Breakthrough T1D Industry Discovery and Development Partnership (IDDP) grant to develop a T1D-derived islet cell platform aimed at understanding and protecting insulin-producing β cells in people with type 1 diabetes.Over 9.5 million people globally live with T1D, expected to rise to 14.7 million by 2040. Although T1D stems from an autoimmune attack on the pancreas, it shows significant variation among individuals, eve...

MIAMI--(BUSINESS WIRE)--Arcadia Capital, the premier strategic advisor and investment bank to leaders in the tech and tech services ecosystem, served as exclusive financial advisor to InformedDNA ("IDNA" or "the Company"), a portfolio company of Truehelm and QHP Capital, in the divestiture of its Genetic Testing Utilization Management ("GTUM") business unit to Zyter, a subsidiary of Infinite, a global technology company. The transaction marks the Company's continued investment in and focus on D...